These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 18308215)

  • 21. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4.
    Murata Y; Mizuno S; Kishiwada M; Hamada T; Usui M; Sakurai H; Tabata M; Inoue H; Shiraishi T; Isaji S
    Pancreas; 2012 Jan; 41(1):130-6. PubMed ID: 21934551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection versus palliation: treatment of stage III and IVA carcinomas of the pancreas employing intraoperative radiation.
    Okamoto A; Tsuruta K; Karasawa K; Miyanari N; Matsumoto G; Kamisawa T; Egawa N
    World J Surg; 2003 May; 27(5):599-605. PubMed ID: 12715231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
    Falk J; Keidan R; Rigo PK; Dmuchowski C
    Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
    Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
    Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant treatment for resectable pancreatic cancer.
    Chua YJ; Cunningham D
    J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early experience with intraoperative radiotherapy in patients with resected pancreatic adenocarcinoma.
    Messick C; Hardacre JM; McGee MF; Siegel CT; Stellato TA; Sanabria JR; Kinsella TJ; Schulak JA
    Am J Surg; 2008 Mar; 195(3):308-11; discussion 312. PubMed ID: 18207129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy, local control and survival in carcinomas of the exocrine pancreas.
    Cellini N; Trodella L; Valentini V; Doglietto GB; Morganti AG; Ziccarelli P; Alfieri S; Bossola M; Brizi MG; Crucitti F
    Rays; 1998; 23(3):528-34. PubMed ID: 9932470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.